Emergent BioSolutions (EBS) Ending Cash Balance (2009 - 2026)
Emergent BioSolutions' Ending Cash Balance was $176.9 million in Q3 2026, down 29.0% from $249.2 million a year earlier but up 25.6% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, Ending Cash Balance at Emergent BioSolutions came in at $209.1 million, up 98.0% from FY2024.
- Ending Cash Balance shows a five-year compound annual growth rate of -19.6% (FY2020 to FY2025).
- In earlier years, Ending Cash Balance was $105.6 million in FY2024 (-5.5%), $111.7 million in FY2023 (-82.6%), $642.6 million in FY2022 (+11.5%) and $576.3 million in FY2021 (-7.3%).
- Quarterly Ending Cash Balance has moved between $71 million (Q2 2024) and $642.6 million (Q4 2022) over five years.
- Compared with a year earlier, Ending Cash Balance was higher in five of the last eight quarters, with growth averaging 57.0%.
- The best year-over-year quarter for Ending Cash Balance over five years was Q2 2025 (growth of 281.7%); the worst was Q4 2023 (a decline of 82.6%).
- Per Business Quant data, EBS's Ending Cash Balance in the three quarters before Q3 2026 was $140.9 million (Q2 2026), $161.5 million (Q1 2026) and $209.1 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Emergent BioSolutions | 309.85 Mn | -371.25 Mn | 29.20 Mn | 176.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 176.90 Mn |
| Jun 30, 2026 | 140.90 Mn |
| Mar 31, 2026 | 161.50 Mn |
| Dec 31, 2025 | 209.10 Mn |
| Sep 30, 2025 | 249.20 Mn |
| Jun 30, 2025 | 271.00 Mn |
| Mar 31, 2025 | 152.80 Mn |
| Dec 31, 2024 | 105.60 Mn |
| Sep 30, 2024 | 156.40 Mn |
| Jun 30, 2024 | 71.00 Mn |
| Mar 31, 2024 | 79.00 Mn |
| Dec 31, 2023 | 111.70 Mn |
| Sep 30, 2023 | 87.80 Mn |
| Jun 30, 2023 | 88.60 Mn |
| Mar 31, 2023 | 430.20 Mn |
| Dec 31, 2022 | 642.60 Mn |
| Sep 30, 2022 | 241.00 Mn |
| Jun 30, 2022 | 358.30 Mn |
| Mar 31, 2022 | 436.00 Mn |
| Dec 31, 2021 | 576.30 Mn |
API Access
Emergent BioSolutions Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();